Penatalaksanaan HIV dalam Kehamilan
DOI:
https://doi.org/10.59581/diagnosa-widyakarya.v1i2.178Keywords:
HIV, pregnancy, ARVAbstract
HIV infection has been a global epidemic around the world. in the absence of intervention, the rates of HIV transmission during pregnancy, labor or breastfeeding vary from 15-45%. Data from Indonesia Health ministry 2011 shows 21.103 pregnancy women who undergone HIV test 534 (2,5%) are positive HIV infected. The use of antiretroviral (ARV) drugs has been success prevent mother to child transmission. Zidovudine monotherapy shows transmission rates (4,8%) higher than ARV combination. ARV combination that can use during pregnancy vary from triple NRTI, 2 NRTI + NNRTI, or 2 NRTI + PI with similar high virological supression rates. it has beeen shows a changing trend from sectio caesar to vaginal delivery with decrease of viral load using ARV combination, with increase percentage for vaginal delivery from 17% to 52%. Women who receive >9 weeks pre partum prophylaxis significantly have undetectable viral load in plasma and breast milk during labor.
References
Aebi-popp K, Mulcahy F, glass TR, Rudin C, Tejada BM, et al. Missed Opportunities Among HIV-Positive Women To Control Viral Replication During Pregnancy And To Have A Vaginal Delivery. J acquir immune defic syndr September 2013; 64: p 58-65
Arikunto S. Prosedur penelitian : suatu pendekatan praktik. Jakarta : Rineka Cipta, 2010.
Aziz N, sokoloff A, leva NV, mendiola ML, Levison J, et al. Time to viral load supression in antiretroviral-naive and experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation. BJOG 2013;120:p 1534-1547
Barral MFM, Oliveira GR, Lobato RC, Mendoza-sassi RA, Martinez AMB, Goncalves CV. Risk Factors Of HIV-1 Vertical Transmission (VT) And The Influence Of Antiretroviral Therapy (ART) In Pregnancy Outcome. Rev.inst.med.trop. sao paulo 2014 March-April; 56: p. 133-8.
Bera E, Mia R. Safety Of Nevirapine In HIV- Infected Pregnant Women Initiating Antiretroviral Therapy At Higher CD4 Counts: A Systematic Review And Meta-Analysis. SAMJ november 2012; 102: p 855-59
Briand N, Jasseron C, Sibiude J, et al. Cesarean Section For HIV-Infected Women In The Combination Antiretroviral Therapies Era, 2000-2010. Am J Obstet Gynecol 2013;209:335.e1-12.
Colbers APH, Hawkins DA, Gingelmaier A, Kabeya K, Rockstroh JK, et al. The Pharmacokinetics, Safety And Efficacy Of Tenofovir And Emtricitabine In HIV-1 Infected Pregnant Women. AIDS 2013; 27: p 739-48
Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment: Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 2010; 331 (18): p 1173-80.
Fayet-mello A, Buclin T, Guignard N, Cruchon S, Cavassini M, et al. Free And Total Plasma Levels Of Lopinavir During Pregnancy, At Delivery And Postpartum: Implications For Dosage Adjustments In Pregnant Women. International medical press 2013; 18: p 171-182
Ford N, Mofenson L, Shubber Z, Calmy A, Andrieux-meyer I, et al. Safety of efavirenz in the first trimester of pregnancy: an update systematic review and meta-analysis. AIDS 2014; 28: p 123-31
Lallemant M, Jourdain G, Coeur SL, et al. A Trial of Shortened Zidovudine Regimens to Prevent Mother to Child Transmission of Human Immunodeficiency Virus Type 1. N Engl J Med 2010; 343: p 982-91.
Menteri Kesehatan. Peraturan Menteri Kesehatan Republik Indonesia No 51 Tahun 2013 tentang pedoman pencegahan penularan HIV ibu ke anak. 2013 : p 3-4
Mulder JW, Cooper DA, Mathiesen L, et al. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. AIDS 2010; 8 (3): p 313-21.
Nachega JB, Uthman OA, Anderson J, Peltzer K, Wampold S, Cotton MF, et al. Adherence To Antiretroviral Therapy During And After Pregnancy In Low-Income, Middle-Income And High-Income Countries: A Systematic Review And Meta-Analysis. AIDS. 2012; 26: p 2040-52
Nielsen-saines K, Watts H, Veloso VG, Bryson YJ, Joao EC, et al. Three postpartum antiretroviral regimens to prevent intrapartum HIV infection. N engl j med june 2012;366;25: p 2368-79
Palombi L, Pirillo MF, Andreotti M, Liotta G, Erba F, et al. Antiretroviral Prophylaxis For Breastfeeding Transmission In Malawi: Drug Concentrations, Virological Efficacy And Safety. International medical press 2012; 17: p 1511-19
Santini oliviera M, Friedman RK, Veloso VG, Cunha CB, et al. Incidence of antiretroviral adverse drug reactios in pregnant women in two referral centers for HIV prevention of mother-to-child-transmission care and research in Rio de Janeiro, Brazil. Braz j infect dis 2014;18(4); p 372-8
Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, et al antiretroviral regimens in pregnancy and Breast-feeding in bostwana. N engl j med june 2010; 362;24: p 2282-94
Sibiude J, Warszawski J, tubiana R, Dollfus C, Faye A, et al. Premature Delivery In HIV- Infected Women Starting Protease Inhibitor Therapy During Pregnancy: Role Of The Ritonavir Boost?. CID may 2012; 54: p 1348-60
Soriano V, Araste K, Migrone H, Lutz T, Opravil M, et al. Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN trial. Antiviral therapy 2011;11: p 339-48
Unger JA, Richardson BA, Otieno PA, et al. Mode Of Delivery And Postpartum HIV-1 Disease Progression And Mortality In A Kenyan Cohort. Pregnancy and Childbirth 2014; 14: 257: p 1-8.
Uzoma OI, Anolue F, Dike E, Okeudo C. HIV In Pregnancy: Severity Of Maternal Disease A Determinant Of Pregnancy Outcomes. WebmedCentral OBSTETRICS AND GYNAECOLOGY 2015;6(2):WMC004686
Ziske J, Kuns A, Sewangi J, Lau I, et al. Hematological changes in women and infants exposed to an AZT-containing regimen for prevention mother-to-child-transmission of HIV in Tanzania. PLOS ONE february 2013; 8: e55633
